Related Experiment Videos

Fetal erythropoiesis in juvenile chronic myelocytic leukemia

Blood
|September 1, 1983
PubMed

Insights

Juvenile chronic myelocytic leukemia (JCML) in a child showed elevated red blood cell enzymes and metabolites, suggesting a young cell population. These findings support the theory that JCML involves a reversion to fetal erythropoiesis.

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Biochemistry

Background:

  • Juvenile chronic myelocytic leukemia (JCML) is a rare hematologic malignancy in children.
  • Understanding the underlying pathophysiology of JCML is crucial for diagnosis and treatment.
  • Red blood cell (RBC) metabolism offers insights into erythropoiesis and disease states.

Observation:

  • Evaluated RBC enzymes and metabolites (2,3-DPG, ATP) in a JCML patient at diagnosis and during disease progression.
  • Assessed age-dependent enzymes (hexokinase, aldolase, pyruvate kinase, G6PD) and non-age-dependent enzymes (G3PD, phosphoglycerate kinase, enolase).
  • Monitored enzyme activities and metabolite concentrations over a 6-month period.

Findings:

  • Elevated activities of age-dependent RBC enzymes and increased concentrations of 2,3-DPG and ATP were observed.
  • Non-age-dependent enzyme activities were also increased, similar to or exceeding levels in term infants.
  • Progressive increase in RBC glyceraldehyde-3-phosphate dehydrogenase (G3PD) and marked increase in phosphoglucose isomerase activity were noted as the disease advanced.

Implications:

  • The metabolic profile suggests a young RBC population with increased glycolytic rate in JCML.
  • Findings support the hypothesis that JCML represents a reversion to fetal erythropoiesis.
  • Further research into these metabolic alterations may reveal novel therapeutic targets for JCML.

Related Concept Videos